Article 1
The following Article is inserted in Directive 2006/112/EC: ‘Article 129a 1. Member States may take one of the following measures: (a) apply a reduced rate to the supply of COVID-19 in vitro diagnostic medical devices and services closely linked to those devices; (b) grant an exemption with deductibility of VAT paid at the preceding stage in respect of the supply of COVID-19 in vitro diagnostic medical devices and services closely linked to those devices. Only COVID-19 in vitro diagnostic medical devices that are in conformity with the applicable requirements set out in Directive 98/79/EC of the European Parliament and of the Council ( * ) or Regulation (EU) 2017/746 of the European Parliament and of the Council ( ** ) and other applicable Union legislation shall be eligible for the measures provided for in the first subparagraph. 2. Member States may grant an exemption with deductibility of VAT paid at the preceding stage in respect of the supply of COVID-19 vaccines and services closely linked to those vaccines. Only COVID-19 vaccines authorised by the Commission or by Member States shall be eligible for the exemption provided for in the first subparagraph. 3. This Article shall apply until 31 December 2022.